Stay in the know

Discover the latest financial news and exclusive features from Laidlaw

Laidlaw acts as Co-Manager on the $287,500,000 Follow-On Offering for Viking Therapeutics.

Laidlaw is pleased to act as Co-Manager on Vikings 287.5mm dollar offering. Laidlaw Capital Markets was the Sole Book Runner on Viking’s 27.6mm dollar IPO in 2015. VKTX is now over a one [...]

March 31st, 2023|News|

Laidlaw acts as Exclusive Introducing Broker on NLS Pharmaceutics’ Closing of Initial Tranche of US$10.0 Million Purchase Agreement with BVF Partners L.P.

On December 14, 2022, NLS Pharmaceutics (NASDAQ:NLSP,)(NASDAQ:NLSPW) announced the closing of its previously publicized purchase agreement with BVF Partners L.P. ("BVF") comprised of an initial closing of $10 million in exchange for 11,494,253 common shares (or equivalents), [...]

December 19th, 2022|News|

Ready to talk?

Discover how our informed approach will help you achieve your financial goals

Go to Top